The Wnt/b-catenin signaling pathway controls cell fate and neoplastic transformation. Expression of an endogenous stabilized b-catenin (DE3 b-catenin) in mammary epithelium leads to the transdifferentiation into epidermis-and pilar-like structures. Signaling molecules in the canonical Wnt pathway upstream from b-catenin induce glandular tumors but it is not clear whether they also cause squamous transdifferentiation. To address this question we have now investigated mammary epithelium from transgenic mice that express activating molecules of the Wnt pathway: Wnt10b, Int2/Fgf3, CK2a, DE3 b-catenin, Cyclin D1, and dominant negative (dn) GSK3b. Cytokeratin 5 (CK5), which is expressed in both mammary myoepithelium and epidermis, and the epidermis-specific CK1 and CK6 were used as differentiation markers. Extensive squamous metaplasias and widespread expression of CK1 and CK6 were observed in DE3 b-catenin transgenic mammary tissue. Wnt10b and Int2 transgenes also induced squamous metaplasias, but expression of CK1 and CK6 was sporadic. While CK5 expression in Wnt10b transgenic tissue was still confined to the lining cell layer, its expression in Int2 transgenic tissue was completely disorganized. In contrast, cytokeratin expression in CK2a, dnGSK3b and Cyclin D1 transgenic mammary tissues was similar to that in DE3 bcatenin tissue. In support of transdifferentiation, expression of hard keratins specific for hair and nails was observed in pilar tumors. These results demonstrate that the activation of Wnt signaling components in mammary epithelium induces not only glandular tumors but also squamous differentiation, possibly by activating LEF-1, which is expressed in normal mammary epithelium.
The Wnt/b-catenin signaling pathway controls cell fate and neoplastic transformation. Expression of an endogenous stabilized b-catenin (DE3 b-catenin) in mammary epithelium leads to the transdifferentiation into epidermis-and pilar-like structures. Signaling molecules in the canonical Wnt pathway upstream from b-catenin induce glandular tumors but it is not clear whether they also cause squamous transdifferentiation. To address this question we have now investigated mammary epithelium from transgenic mice that express activating molecules of the Wnt pathway: Wnt10b, Int2/Fgf3, CK2a, DE3 b-catenin, Cyclin D1, and dominant negative (dn) GSK3b. Cytokeratin 5 (CK5), which is expressed in both mammary myoepithelium and epidermis, and the epidermis-specific CK1 and CK6 were used as differentiation markers. Extensive squamous metaplasias and widespread expression of CK1 and CK6 were observed in DE3 b-catenin transgenic mammary tissue. Wnt10b and Int2 transgenes also induced squamous metaplasias, but expression of CK1 and CK6 was sporadic. While CK5 expression in Wnt10b transgenic tissue was still confined to the lining cell layer, its expression in Int2 transgenic tissue was completely disorganized. In contrast, cytokeratin expression in CK2a, dnGSK3b and Cyclin D1 transgenic mammary tissues was similar to that in DE3 bcatenin tissue. In support of transdifferentiation, expression of hard keratins specific for hair and nails was observed in pilar tumors. These results demonstrate that the activation of Wnt signaling components in mammary epithelium induces not only glandular tumors but also squamous differentiation, possibly by activating LEF-1, which is expressed in normal mammary epithelium.
Introduction
Wnt signaling controls various aspects of development, including cell fate determination and neoplastic transformation (Cadigan and Korinek et al., 1998; Merrill et al., 2001; Miller and Moon, 1996; Polakis, 2000) . b-catenin is a central molecule in the canonical Wnt signaling pathway, which is activated by secreted proteins from the Wnt family that bind to receptors from the Frizzled protein family (Bhanot et al., 1996; Tekmal and Keshava, 1997; Wodarz and Nusse, 1998) . Upon ligand binding, Dishevelled (dsh) is activated through phosphorylation, possibly by protein kinase CK2, formerly known as casein kinase II (Willert et al., 1997) . Activated dsh in turn inactivates glycogen synthase kinase 3 (GSK3). GSK3 phosphorylates serine and threonine residues in the N-terminus of b-catenin and thus prepares it for ubiquitinmediated degradation (Aberle et al., 1997) . Inactivation of GSK3 inhibits N-terminal phosphorylation of bcatenin, such that b-catenin cannot be degraded and translocates into the nucleus (Behrens et al., 1998) . In a complex with LEF/TCF transcription factors, bcatenin activates target genes, including Cyclin D1 and myc (Behrens et al., 1996; He et al., 1998; Roose et al., 1999; Shtutman et al., 1999; Tetsu and McCormick, 1999) .
Over the past decade transgenic mice have been generated, in which the Wnt pathway is activated. Several strategies have been employed to achieve this. First, molecules that activate the Wnt pathway have been expressed ectopically in mammary epithelium under control of the MMTV-LTR. These include Wnt1 (Tsukamoto et al., 1988), Wnt10b (Lane and Leder, 1997) , Int2/Fgf3 (Lee et al., 1995; Muller et al., 1990) , the a catalytic subunit of CK2 (Landesman-Bollag et al.,
2001
), DN89 b-catenin (Imbert et al., 2001) , b-catenin-DN90 (Michaelson and Leder, 2001) , and a dominant negative form of GSK3b (dnGSK3b) capable of activating Wnt signaling (DC Seldin et al., unpublished) . In addition, one of the major transcriptional targets of the Wnt pathway, Cyclin D1, has been similarly expressed (Wang et al., 1994) . These mice develop mammary tumors with variable latency periods. In another approach, endogenous b-catenin was stabilized through the deletion of exon 3 (DE3 b-catenin, Harada et al., 1999; Miyoshi et al., 2002) , which encodes the Nterminal region that is the target of GSK3b phosphorylation. Interestingly, upon the stabilization of b-catenin in mammary epithelium these mice do not develop glandular tumors and the mammary epithelium undergoes transdifferentiation into epidermal-and pilar-like structures .
The availability of mice, in which different molecules that activate the Wnt pathway are deregulated, provides a unique opportunity to explore their relative contributions to specific developmental and biochemical signaling events. Since the stabilization of b-catenin results in the transdifferentiation of mammary epithelium , and a quarter of the transgenic mammary tumors induced by canonical Wnt pathway molecules represent squamous metaplasias in pilar tumors (Rosner et al., 2002) , we decided to explore whether activation of other components of the Wnt pathway could induce a similar transdifferentiation process. We hypothesized that if these molecules are part of a common signaling pathway, their activation should result in similar phenotypic consequences. To categorize the tumors we analysed the expression of three types of cytokeratins, CK5, CK1 and CK6. CK5 is expressed in both mammary myoepithelium and the basal cell layer in the epidermis (Fuchs and Byrne, 1994; Miyoshi et al., 2002) . In contrast, CK1 and CK6 are not expressed in normal mammary epithelium, but they are detected in epidermis (Fuchs and Byrne, 1994; Miyoshi et al., 2002) . CK1 is expressed in the spinous layer of the epidermis (Fuchs and Byrne, 1994) and CK6 is a marker for proliferating cells in the epidermis, especially in hair follicles (Vasioukhin et al., 2001; Weiss et al., 1984) . Another indicator of transdifferentiation was provided by the antibody AE-13, which recognizes hard keratins specific for hair and nails. Based on this study, the morphology of many lesions in transgenic mice in which the Wnt pathway was activated is reminiscent of hair follicles. Specifically, the expression of follicular keratins connotes a change in mammary epithelial cell differentiation.
Results

Stabilized b-catenin induces transdifferentiation of mammary epithelium
Previously we reported that the deletion of exon 3 of the b-catenin gene (DE3 b-catenin) in mammary epithelium resulted in the generation of stabilized bcatenin and the transdifferentiation of mammary epithelium into epidermis-and pilar-like structures during the first pregnancy . Pilar mammary tumors are characterized by abortive hair shafts, ghost cells, confluent swirls of laminar keratin corresponding to former dilated ducts with excessive squamous metaplasia, or combinations of these. Squamous nodules are frequent dysplasias of the mouse mammary gland and have either abortive hair shafts or confluent keratin swirls. In DE3 b-catenin mice, we detected all characteristics of these pilar tumors and extensive transdifferentiation was observed in females that had gone through one pregnancy ( Figure 1A ). Here we analysed six additional mice (Table 1) . Keratin deposits or laminae were found in dysplastic squamous nodules ( Figure 1A , I and II). The outer layers of the nodules expressed CK5 ( Figure 1A , III and IV), and the more central layers expressed CK1 ( Figure 1A , V and VI). CK6 expressing cells were frequently located between the CK5 and CK1 layers, and some were interspersed with CK1 expressing cells ( Figure 1A , VII and VIII). The acellular keratin lamellae did not stain.
Ligand of Wnt signaling pathway: Wnt10b
Expression of Wnt10b under control of an MMTV-LTR (Wnt10b mice) results in the development of mammary glandular tumors in both males and females (Lane and Leder, 1997). We also detected limited squamous hyperplasias that showed abortive hair shafts ( Figure 1B , I and II), ductular structures filled with keratin, which are usually found at the circumference of the tumor. The pattern of cytokeratin expression was investigated in mammary tissue from a Wnt10b transgenic male. CK5 was expressed in the outer cell layer of the tumor mass and on the luminal side ( Figure 1B , III and IV). In contrast, the epidermal differentiation markers CK1 and CK6 were expressed sporadically in the center of the glandular tumors ( Figure 1B , V-VIII) ( Table 1) .
Kinases of the Wnt signaling pathway: CK2a and dnGSK3b
Expression of either the a catalytic subunit of CK2 (CK2a, Landesman-Bollag et al., 2001), or a dominant negative GSK3b (dnGSK3b, DC Seldin et al., unpublished) under control of an MMTV-LTR induces mammary tumors correlated with increased levels of bcatenin. The dnGSK3b is known to antagonize the wild type kinase and promote Wnt signaling in Xenopus embryos. CK2 impinges on the Wnt pathway in multiple places, as it is one of the kinases that phosphorylates dsh during Wnt signaling (Willert et al., 1997) and it is also capable of phosphorylating bcatenin directly, and stabilizing it (Song et al., 2000) . Here we have analysed mammary tissue from three multiparous females that contained squamous nodules with epidermal-like keratinization patterns ( Expression of dnGSK3b resulted in a phenotype similar to that seen in DE3 b-catenin mice (compare Figures 1A and 2B, I and II). Squamous metaplasias were found in all five females analysed (Table 1) . In addition to the keratinization, we observed extensive A target gene of the Wnt pathway: Cyclin D1
Cyclin D1 is a target gene of the canonical Wnt pathway and MMTV-Cyclin D1 transgenic mice develop hyperplasias and glandular tumors with papillary elements or squamous metaplasias after 12 to 15 months of age (Wang et al., 1994) . We analysed a parous female that had developed several pilar dysplasias. Figure 3A shows a mass of cells that surround squamous nodules (panels I and II). These squamous nodules contained abortive hair shafts and keratin debris. The patterns of cytokeratin staining were similar to that seen in DE3 b-catenin mammary tissue. CK5 was expressed in the outer layers of the nodules ( Figure 3A , III and IV), and CK1 was found in the center of the ghost cells ( Figure 3A , V and VI). CK6 was expressed in the inner cell layers of the tumors next to ghost cells ( Figure 3A , VII and VIII). A total of five mice were analysed and exhibited squamous metaplasias (Table 1) .
A Wnt cooperating gene: Int2/Fgf3
The Int2/Fgf3 gene is frequently activated through MMTV proviral insertions similar to Int1/Wnt1 (Peters et al., 1984) . Transgenic mice that express Int2/Fgf3 under control of an MMTV-LTR (Int2/Fgf3 mice) develop ductal hyperplasias, stromal proliferation and mammary tumors within 10 months of age (Lee et al., 1995; Muller et al., 1990) . In tissue from three multiparous females we detected pilar type lesions ( Figure 3B and Table 1 ). Ghost cells, i.e. dead cells with fully keratinized cytoplasm, are frequently seen in the centers of concentric keratin swirls, or they fill the lumen of pilar neoplastic ductules. In some cases they are located within CK5 was expressed in the outer layers of the nodules (I -IV). CK1 was expressed inside the nodules (V -VI, arrows). CK6 staining patterns were similar to hair follicles in wild type skin (VII -VIII, arrows). (B) MMTV-dnGSK3b transgenic mammary tissue. CK5 was highly expressed in several outer layers of nodules (I -IV). CK1 was expressed in the inner layers (V -VI, arrows). CK6 was highly expressed in several layers (VII -VIII, arrows). II, IV, VI, VIII; 36 higher magnifications of the circled areas shown in I, III, V, VII, respectively dense stroma with inflammatory infiltrates lacking surrounding epithelial cells, as frequently found in human pilomatricomas ( Figure 3B , I and II). CK5 was expressed in the center of the nodules, possibly in ghost cells, but was absent in outer layers ( Figure 3B , III and IV). CK1 and CK6 were expressed in single cells in the center of the tumor but they did not co-localize. ( Figure  3B , V -VIII). As compared with DE3 b-catenin tissue ( Figure 1A ), these cytokeratin expression patterns appeared disorganized and sporadic.
Expression of LEF and hair keratins
Members of the TCF/LEF HMG domain family are downstream executors of the Wnt signaling pathway and the expression of Tcf-4 has been demonstrated in human mammary epithelium (Barker et al., 1999) . In addition, LEF-1 and b-catenin promote hair cell fate (Merrill et al., 2001) . We have investigated the expression of LEF-1 in mammary epithelium of bcatenin fl/+; WAP-Cre mice at different stages of transdifferentiation. In areas with maintained normal alveolar structures extensive nuclear LEF-1 staining was observed in the secretory alveolar-like epithelium ( Figure 4A) . A different pattern of LEF-1 expression was observed in structures of hyperproliferation and transdifferentiation. Specifically, LEF-1 staining was preferentially perinuclear ( Figure 4B ,C). The expression of CK1 is indicative of early epidermal transdifferentiation. To verify the transdifferentiation to pilar cell type, we performed immunohistochemical analyses using the antibody AE13 (Lynch et al., 1986) , which recognizes hard keratins specific for hair and nails in all pilar mammary tumors ( Figure 4D and Rosner et al., 2002) . We have analysed areas of squamous metaplasia that are representative for the pilar mammary tumors frequently observed in the transgenic mice described in this study. Positive staining was limited to ghost cells and to isolated clusters of tumor cells at the peripheral keratinization zone in disrupted neoplastic ductules of CK2a transgenic mice ( Figure 4D ).
Discussion
Molecules that activate the Wnt signaling pathway have been expressed in mammary epithelium of Lee et al., 1995; Michaelson and Leder, 2001; Muller et al., 1990; Tsukamoto et al., 1988; Wang et al., 1994) . Beta-catenin is the downstream mediating molecule in the canonical Wnt signaling pathway, and we have demonstrated that the stabilization of endogenous b-catenin (exon 3 deletion) in mammary epithelium induces transdifferentiation into epidermis-like structures . We hypothesized that if each molecule in the Wnt pathway simply activates b-catenin, we would observe similar types of squamous metaplasias in the different transgenic mice. We tested this hypothesis and characterized mammary tissue of transgenic mice in which this pathway was activated through the expression of Wnt10b, CK2a, dnGSK3b, Cyclin D1 and DE3 b-catenin. We also explored the consequences of Int2/ Fgf3 overexpression, a secreted molecule that is not directly linked to the Wnt pathway, but is frequently activated through MMTV insertions (Peters et al., 1984) and cooperates in tumor progression with Wnt-1 (Kwan et al., 1992; Mester et al., 1987; Peters et al., 1986) . Transdifferentiation of mammary epithelia into epidermis-and pilar-like structure was observed in all transgenic mice, and we established three distinct cytokeratin staining patterns, which were correlated with specific signaling molecules (Table 1 and Figure  5 ). The CK1 and CK6 expression patterns suggested that the tumors had undergone epidermal-like transdifferentiation and the CK5 expression patterns permitted us to categorize these tumors. The expression of hard keratins specific for hair and nails further confirmed the transdifferentiation process. The variability observed in the tumor latency between the different lines of transgenic mice might be due to inherent differences normally seen in transgenic mice, to differences in potency in activation of b-catenin, or to cross-talk with other signaling pathways in which molecules independently are involved. In addition, the MMTV-LTRs used to activate the various transgenes were not identical and in the case of the N-terminally truncated form of b-catenin, the gene was expressed of its endogenous promoter, which most likely has a different regulation than an MMTV-LTR. Furthermore, the transgenic integration sites in combination with the outbred status of the mice are reasons for differences. Expression of Wnt10b and Int2/Fgf3 induced unique cytokeratin expression patterns and CK2a, DE3 bcatenin, dnGSK3b and Cyclin D1 mice shared features. In mice that express stabilized b-catenin from its endogenous promoter mammary epithelia transdifferentiate into the epidermis and we detected distinct cytokeratin expression patterns in the nodules from the outer to inner layers, similar to that seen in epidermis differentiation from the basal layer to the surface. Although Wnt10b and Int2/Fgf3 induced mainly glandular tumors, we also detected squamous metaplasias. Whereas in Wnt10b tumors CK5 was expressed in an organized pattern in the periphery of the tumor mass, expression in Int2/Fgf3 tumors was disorganized. Specifically, in Int2/Fgf3 tumors, transdifferentiation was initiated in a small number of cells and follicular (or pilar) structures without the establishment of a full set of characteristics. This may be explained by the fact that Int2/Fgf3 can activate a Figure 5A ), including MAP kinase, protein kinase B, and protein kinase C (PKC) (Klint and Claesson-Welsh, 1999) . Our findings support the notion that Wnt10b also activates other signaling pathways, such as PKC (Cook et al., 1996) to induce tumors ( Figure 5A ).
Expression of CK2a and dnGSK3b resulted in similar cytokeratin patterns, suggesting that they enhance b-catenin signaling in the same way as DE3 b-catenin. This is consistent with the roles of these kinases in the regulation of b-catenin and the elevation of b-catenin seen in mammary tumors in these transgenics (Landesman-Bollag et al., 2001; Song et al., 2000) . Similarly, the tumor suppressor adenomatous polyposis coli (APC) directly controls b-catenin stability and mice that carry mutant APC alleles develop spontaneous mammary squamous cell carcinomas (Moser et al., 1993; Muller et al., 1990; van der Houven van Oordt et al., 1997) . The Cyclin D1 gene is a proposed b-catenin target gene and its overexpression results in squamous metaplasias with a cytokeratin expression pattern similar to that seen in DE3b-catenin mice. In contrast, the other known target gene of bcatenin in tumors, c-myc, induces mainly mammary glandular tumors (Stewart et al., 1984) , suggesting that although the canonical Wnt pathway can induce the development of mammary squamous metaplasias, activation of this target gene alone is not sufficient. Figure 5B ). It should be noted that b-catenin can be activated by Wnt-independent pathways, such as TGFb (Smad) and HGF/EGF (Beavon, 2000) . Furthermore, our study suggests that signaling pathways independent of bcatenin contribute to the establishment of glandular tumors ( Figure 5B ). Lastly, cell-specific components determine the fate of a cell after the stabilization of bcatenin. While the stabilization of b-catenin through the deletion of exon 3 in mammary and intestinal epithelium results in the formation of squamous metaplasias and polyps (Harada et al., 1999; , respectively, no such foci were observed in liver expressing the stabilized b-catenin (Harada et al., 2002) . The molecular basis for this observation could be differential expression of proteins from the TCF/LEF family or the need of additional mutations.
The importance of Wnt signaling for skin differentiation has recently been confirmed by several reports. Deletion of b-catenin in basal cells of the epidermis inhibits the formation of hair follicles (Huelsken et al., 2001) . Similarly, expression of DNLef1, which lacks the b-catenin binding site, in basal cells results in differentiation of hair follicles into squamous epidermal cysts (Niemann et al., 2002) . Data using various mutant forms of Tcf3 and Lef1 demonstrate that cell fate determination in the skin is dependent on the relative levels of these b-catenin binding partners (Merrill et al., 2001) and further support our observation of transdifferentiation of mammary epithelial cells by modulating the Wnt signaling pathway.
Materials and methods
Transgenic mice
Mammary tissue was harvested from transgenic mice expressing Wnt10b (Lane and Leder, 1997), Int2/Fgf3 (Lee et al., 1995; Muller et al., 1990 ), CK2a (Landesman-Bollag et al., 2001 , dominant negative GSK3b (dn GSK3b) (DCS, unpublished) and Cyclin D1 (Wang et al., 1994) under control of an MMTV-LTR. The DE3 b-catenin gene was under control of its own promoter and deletion was induced by Cre recombinase from a WAP-Cre transgene . We analysed at least one sample from each transgenic mouse and chose sections that are representative of the histopathology normally observed in these strains. The age of mice that we used here are indicated in Table 1 .
Immunohistochemistry
The fixed samples were embedded in paraffin and sectioned at 5 mm. After deparaffinization, dehydration and antigen retrieval by heating in antigen unmasking solution (Vector Laboratories), primary antibodies (cytokeratin 1, 5, or 6, Babco, 1 : 200; b-catenin, Transduction Labs; 1 : 100) were applied to the sections. After incubation at 378C for 1 h, the sections were washed with PBS and incubated with Texas Red-conjugated anti-rabbit (Alexafluor 594) and FITCconjugated anti-mouse (Alexafluor 488) secondary antibodies (Molecular Probes, 1 : 400) at 378C for 30 min. Slides were observed using a Zeiss Axioscop (equipped with filters for FITC, TRITC and FITC : TRITC). Within the mammary tissue adjacent to the tumor, we also analysed normal mammary ducts/alveoli, dysplasias with/without squamous metaplasias, and non-squamous tumors. We captured the images with the strongest staining in squamous metaplasias in each group. Immunohistochemistry with the antibody AE13 was performed as described (Lynch et al., 1986) . IHC for hard (hair) keratin was performed on five pilar mammary tumors (transgenes: Int2, Casein kinase 2a, and dnGSK3b) using a 1 : 20 diluted cell culture supernatant with the mouse monoclonal primary antibody AE-13. The Animal Research Kit (DAKO) with peroxidase was used as amplification system according to manufacturer's instructions.
